Pfizer Stops Developing Weight-Loss Pill [gPH916MRVJu]

Pfizer stops developing its experimental weight-loss pill. More than half of patients in the study had to stop taking danuglipron due to nausea and vomiting, according to a statement Friday. The shares dropped 3.4% in trading before US markets opened.  Follow Bloomberg for business news & analysis, up-to-the-minute market data, features, profiles and more: Connect with us on... Twitter: Facebook: Instagram: #synergy medical weight loss #biolyfe keto gummies website #keto gummies real #best night time diet pills #boost line keto gummies